The Trans Pacific Partnership appears to have reached a stalement with the withdrawal of the United States from the agreement. While there is still some speculation about the remaining countries negotiating trade deals, for the time being this campaign will be suspended. Any trade deals, bilateral or otherwise, will be watched with the hope that patent protections and Intellectual Property provisions are not as devastating as what was in the TPP.
The spread and impact of HIV on the grandmothers, children and their communities are inextricably linked to obstacles to access to medicines, a fundamental element of the Human Right to Health as noted in the World Health Organization’s Constitution.
The issue of access to medicines is also reflected in both the UN Millennium Development Goals which expire in 2015 and their replacements, the Sustainable Development Goals which are due to be adopted this year. Both include the following goal: Ensure healthy lives and promote well being for all at all ages.
Advocating for access to affordable life saving medicines has been at the core of GRAN's mandate since our beginning. Our work began with efforts to affect legislative changes to the Canadian Access to Medicines Regime (CAMR) that would have facilitated Canadian exports of affordable generic antiretroviral medicines to the developing world. Our work has since focused on intellectual property issues in trade agreements, pushing for Canada’s fair contribution to the Global Fund to fight AIDS, Tuberculosis and Malaria and supporting the work of the Medicines Patent Pool. It is presently being broadened to include a campaign on improving access to affordable life-saving vaccines.